AIDS Treatment News
Table of Contents, October 31, 2003

• Lexiva (Fosamprenavir) Approved
  The FDA approved a prodrug that becomes amprenavir in the body, but has practical advantages over amprenavir.

• Warning Against Once-Daily Tenofovir+ddI+3TC, and "Triple Nuke" Combinations
  Another regimen consisting only of nucleoside-analog drugs has shown unsatisfactory suppression of HIV.

• Clinton Foundation Gets Big Price Reduction -- to 40 Cents a Day for Three-Drug Combination
  The price of triple-combination antiretroviral treatment in poor countries can now be less than 40 cents a day.
  Advertisement
• Retroviruses Conference Reminder: Community, Press Deadlines November 14
  Anyone attending the Retroviruses conference in February as either community scholarship or community press must apply by the November 14 deadlines.

• Thailand International Conference Submission Deadlines (Theme: Access for All)
  Deadlines and other information on the big International AIDS Conference in summer 2004.

• Clinical Trials Forum: World AIDS Day (December 1), Boston
  Researchers and volunteers in clinical trials currently open to persons with HIV will explain their trials, and what one should consider when deciding whether to volunteer.

• Returning to Work After Disability: What You Should Know
  A leader in the movement to help people consider returning to work after disability looks at some of the medical, financial/legal, vocational, and psychosocial issues involved -- and how to get help with them (interview, part 1 of 2).

ISSN # 1052-4207

Copyright 2003 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.